The Discounted Cash Flow (DCF) valuation of Acceleron Pharma Inc (XLRN) is (425.77) USD. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on DCF is -338.2%.
Based on the latest price of 178.75 USD and our DCF valuation, Acceleron Pharma Inc (XLRN) is a sell. selling Acceleron stocks now will result in a potential gain of 338.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 7.7% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,067.12) - (269.06) | (425.77) |
| Upside | -697.0% - -250.5% | -338.2% |